Collaboration with the clinical team on the type 1 diabetes (T1D) beta-islet transplantation program.
External and internal communication on the T1D program.
Endocrinology/T1D expertise for preclinical and early phase pipeline products.
Clinical oversight and/or medical monitor of the CNTY-813 clinical trial and other trials as needed.
Candidates located around our sites in Philadelphia/Boston/Branchburg, NJ are preferred but remote candidates in the United States will also be considered.
Qualifications
Physician (MD or DO a prerequisite) or physician/scientist (PhD in relevant field is desirable) with >5 years industry and clinical experience.
Skills
Strong track record in type 1 diabetes clinical trials, experience in early phase trials.
Experience in pivotal phase or registration trials preferred
Experience establishing and working with data monitoring committees, safety review committees, and independent response adjudication committees.
Excellent verbal, written, communication and interpersonal skills.
Driven by scientific curiosity with track record of independent clinical, laboratory or translational research in the academic and/or industry setting.
Strong team player able to effectively communicate and collaborate across functions and job levels.
Willing and able to adjust to multiple demands and shifting priorities as well as an ability to meet day-to-day challenges with confidence and professionalism.
Routinely takes initiative, makes strategic decisions, and is highly engaged and accountable for all parts of assigned projects.
Detail-oriented with expertise in hypothesis testing methods, statistical design, and data interpretation.
Education
Fellowship in Endocrinology with Board certification or similar level of experience is desirable.
Additional Requirements
Ability to travel for site visits, conferences, and to Century's offices in Philadelphia/Boston/Branchburg, NJ for meetings as required.